Literature DB >> 11919094

Nut allergy in schoolchildren: a survey of schools in the Severn NHS Trust.

J C Watura1.   

Abstract

AIMS: To assess the extent of the problem of nut allergy in schoolchildren within the Severn NHS Trust. To determine how well informed schools are about the condition, their policies and attitudes, and the action that would be taken in the event of an acute reaction.
METHODS: A questionnaire addressed to the head teacher was sent to 100 randomly selected mainstream schools in the Severn NHS Trust.
RESULTS: Response rate was 83%. There were a total of 21 868 pupils in the schools. Forty five (54%) schools had at least one child currently known to be allergic. The total in all the schools was 87 (0.4%). Only 31 (36%) children had medication available in school. Of these, 18 (58%) had EpiPen alone. Twenty schools (44%) with an allergic child either had no staff trained to administer medication or did not respond to the question. Two (4%) schools with an allergic child had a support assistant for the pupils. Only 19 (43%) schools with a nut allergic child gave information to all teachers about nut allergy and only 21 (47%) gave information to dinner supervisors and other assistants. In only 23 (51%) schools with an allergic child were the cook and catering staff aware of all the children with a nut allergy. Ten (22%) schools with an allergic child served only "nut free dinners". Fourteen (31%) schools with a nut allergic child could not name a single sign of a mild acute allergic reaction (compared to 34 (89%) schools without an allergic child). Fifteen (33%) schools with an allergic child could not state a single sign of a severe acute allergic reaction (compared with 33 (87%) schools without a nut allergic child).
CONCLUSION: Schools are not sufficiently well informed about nut allergy and management of acute allergic reactions. Policies and attitudes vary. We have revised the information given to schools regarding nut allergy and prepared a new information pack.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11919094      PMCID: PMC1719143          DOI: 10.1136/adc.86.4.240

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  2 in total

1.  Cohort study of peanut and tree nut sensitisation by age of 4 years.

Authors:  S M Tariq; M Stevens; S Matthews; S Ridout; R Twiselton; D W Hide
Journal:  BMJ       Date:  1996-08-31

2.  Definitive diagnosis of nut allergy.

Authors:  D Armstrong; G Rylance
Journal:  Arch Dis Child       Date:  1999-02       Impact factor: 3.791

  2 in total
  6 in total

1.  Does affluence affect allergy preparedness?

Authors:  Ann Clarke; Lawrence Joseph
Journal:  Can J Public Health       Date:  2005 Jul-Aug

2.  The effect of income on anaphylaxis preparation and management plans in Toronto primary schools.

Authors:  David W Frost; Catherine G Chalin
Journal:  Can J Public Health       Date:  2005 Jul-Aug

Review 3.  Food allergy in children.

Authors:  V R Baral; J O'B Hourihane
Journal:  Postgrad Med J       Date:  2005-11       Impact factor: 2.401

4.  Serious shortcomings in the management of children with anaphylaxis in Scottish schools.

Authors:  Kirsty E Rankin; Aziz Sheikh
Journal:  PLoS Med       Date:  2006-08       Impact factor: 11.069

Review 5.  Safety of fexofenadine and other second-generation oral antihistamines before and after the removal of the prescription requirement in Italy and other European countries: A real-world evidence study and systematic review.

Authors:  Carla Carnovale; Vera Battini; Michele Gringeri; Marina Volonté; Maria Chiara Uboldi; Andrea Chiarenza; Giovanni Passalacqua
Journal:  World Allergy Organ J       Date:  2022-07-02       Impact factor: 5.516

6.  A survey of school's preparedness for managing anaphylaxis in pupils with food allergy.

Authors:  George Raptis; Mercedes Perez-Botella; Rebecca Totterdell; Konstantinos Gerasimidis; Louise J Michaelis
Journal:  Eur J Pediatr       Date:  2020-04-05       Impact factor: 3.183

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.